• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Hikma Pharmaceuticals - Articles and news items

asthma-inhaler

Hikma and Vectura to develop and license generic salmeterol for US market

Industry news / 22 November 2016 / Niamh Louise Marriott, Digital Content Producer

Generic salmeterol is a generic long acting beta‐agonists for the treatment of asthma and COPD, delivered using Vectura’s proprietary dry powder inhalation…

xellia

Hikma sells Ben Venue manufacturing facilities to Xellia

Industry news / 26 November 2015 / Victoria White

Xellia has said that it plans to invest significantly in the facilities to resume manufacturing in the four sterile injectable manufacturing plants at the site…

Zevtera

Hikma signs exclusive agreement for Basilea’s Zevtera

Industry news / 15 October 2015 / Victoria White

Under the terms of the agreement, Hikma will have the exclusive rights to register, distribute and market Zevtera in all its Middle Eastern and North African markets…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +